VanEck Pharmaceutical ETF

  • PPH

  • $89.03

  • -1.06%

  • $90.24

  • $90.24

  • $88.87

Ticker Appearances

Daily Technical Strategy
Tue, April 2, 2024 | 6:32PM ET
Mark
Mark L. Newton, CMT AC

Head of Technical Strategy

Minor Bond yield breakout results in SPX selloff to near support

I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...

This report is accessible to
FSI Pro, FSI Macro memberships.

You have viewed the limit of 2 reports for free this month.

To continue reading our research please sign up below.

Already have an account? Sign In

Visitor: cc7da3-396ed3-9470e8-d09e9a-23947d

Daily Technical Strategy
Tue, August 8, 2023 | 5:58PM ET
Mark
Mark L. Newton, CMT AC

Head of Technical Strategy

Pharmaceutical stocks look attractive

MARKETS HAVE ENTERED A WINDOW WHERE A POTENTIAL LOW COULD TAKE PLACE THIS WEEK (LIKELY WEDNESDAY-FRIDAY OF THIS WEEK).  US DOLLAR AND US TREASURY YIELDS...

This report is accessible to
FSI Pro, FSI Macro memberships.

You have viewed the limit of 2 reports for free this month.

To continue reading our research please sign up below.

Already have an account? Sign In

Visitor: cc7da3-396ed3-9470e8-d09e9a-23947d

Daily Technical Strategy
Wed, April 5, 2023 | 5:29PM ET
Mark
Mark L. Newton, CMT AC

Head of Technical Strategy

Defensive trading dominates as Pharma, & Utilities break out

Similar to Tuesday’s mild “down day,” Wednesday’s pullback failed to show sufficient deterioration to expect much follow-through just yet. The key driver of this rally,...

This report is accessible to
FSI Pro, FSI Macro memberships.

You have viewed the limit of 2 reports for free this month.

To continue reading our research please sign up below.

Already have an account? Sign In

Visitor: cc7da3-396ed3-9470e8-d09e9a-23947d

Daily Technical Strategy
Tue, January 31, 2023 | 6:37PM ET
Mark
Mark L. Newton, CMT AC

Head of Technical Strategy

Healthcare should soon hit support and reverse in February

January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...

This report is accessible to
FSI Pro, FSI Macro memberships.

You have viewed the limit of 2 reports for free this month.

To continue reading our research please sign up below.

Already have an account? Sign In

Visitor: cc7da3-396ed3-9470e8-d09e9a-23947d

Daily Technical Strategy
Thu, December 22, 2022 | 6:17PM ET
Mark
Mark L. Newton, CMT AC

Head of Technical Strategy

Happy Holidays !!  Homebuilders and Pharma stocks favored

Happy Holidays. Hope your holiday season proves safe, happy and healthy.  I will be taking the final week off to spend with my family during...

This report is accessible to
FSI Pro, FSI Macro memberships.

You have viewed the limit of 2 reports for free this month.

To continue reading our research please sign up below.

Already have an account? Sign In

Visitor: cc7da3-396ed3-9470e8-d09e9a-23947d

Daily Technical Strategy
Mon, November 14, 2022 | 6:27PM ET
Mark
Mark L. Newton, CMT AC

Head of Technical Strategy

Biotech breakout worth following as Healthcare gets stronger

The near-term picture still looks positive for US benchmark indices and while momentum has reached intra-day overbought levels, this doesn’t imply a selloff has to...

This report is accessible to
FSI Pro, FSI Macro memberships.

You have viewed the limit of 2 reports for free this month.

To continue reading our research please sign up below.

Already have an account? Sign In

Visitor: cc7da3-396ed3-9470e8-d09e9a-23947d

Events

Tickers

Trending tickers in our research